Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Effect of the Erchonia® EVRL™ for Prescription Home Use Application in Providing Temporary Relief From Idiopathic Peripheral Neuropathy Foot Pain

NCT06912646 is registered in ClinicalTrials.gov with Erchonia Corporation as lead sponsor.

NCT NCT06912646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06912646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Effect of the Erchonia® EVRL™ for Prescription Home Use Application in Providing Temporary Relief From Idiopathic Peripheral Neuropathy Foot Pain
Lead sponsor
Erchonia Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2025
Completion date
June 16, 2027
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathy, neuropathy;peripheral